Serotonergic and glutamatergic neurons at the ventral medullary surface of the human infant: Observations relevant to central chemosensitivity in early human life
Introduction
Central chemoreception is the mechanism by which the brain detects the level of carbon dioxide (CO2) in the arterial blood and alters breathing accordingly in order to maintain CO2 within physiological levels (Nattie, 2001). Central chemoreceptors are located primarily in the brainstem, and detect changes in CO2 via attending changes in pH (Nattie, 2001, Rodman et al., 2001, Feldman et al., 2003, Richerson, 2004). Recently, both serotonergic (5-HT) (Wang et al., 2001, Richerson, 2004, Richerson et al., 2001, Messier et al., 2004, Nattie et al., 2004, Taylor et al., 2004) and glutamatergic (Glut) (Mulkey et al., 2004, Weston et al., 2004) neurons at the ventral medullary surface (VMS) of rats have been shown to exhibit properties of CO2 chemoreceptors. Both 5-HT and Glut neurons increase their firing rate in response to elevated CO2 and subsequently stimulate respiration through their projections to major respiratory regions in the brainstem and spinal cord. In addition, astrocytes may be central chemoreceptors (Higashi et al., 2001, Wellner-Kienitz et al., 1998), as specific lesions of astrocytes at the VMS in rats attenuate respiratory responses to elevated pCO2 (Erlichman et al., 1998, Holleran et al., 2001). It is possible that “chemosensitive” 5-HT and Glut neurons are stimulated to fire by neurotransmitter released from astrocytes in response to elevated pCO2, rather than any intrinsic chemosensitive nature. The roles of 5-HT neurons, Glut neurons, and astrocytes, and their interactions with each other in the mediation of chemosensitivity at the VMS remain unclear.
The positionally homologous region to the VMS in experimental animals in the human medulla oblongata includes neuron clusters labeled collectively as the arcuate nucleus. The Arc has been historically considered as a precerebellar nucleus that is composed, at least in part, of downwardly displaced neurons from the basis pontis, and is putatively involved in motor coordination (Rasmussen and Peyton, 1946). Evidence exists, however, to support a role for the Arc in respiratory chemosensitivity, including morphological and topographical homology between Arc neurons and neurons in the chemosensitive fields at the VMS in cats (Filiano et al., 1990), increased of firing of neurons at the VMS, demonstrated by functional neuroimaging upon exposure of human adult experimental subjects to carbon dioxide (CO2) (Gozal et al., 1994), absence of the Arc in an autopsied infant with clinically documented central insensitivity to CO2 (Folgering et al., 1979), and abnormalities in the Arc in sudden infant death syndrome (SIDS) (Filiano and Kinney, 1992, Matturri et al., 2000, Matturri et al., 2004, Gilson et al., 1994, Biondo et al., 2003, Panigrahy et al., 1997, Panigrahy et al., 2000, Kinney et al., 1995), a putative disorder of compromised responses to elevated CO2 (Kinney et al., 2001).
Based upon these combined observations, and the recent observations that 5-HT and Glut neurons are CO2 detectors at the VMS of the rat, we hypothesize that the Arc is homologous to the respiratory chemosensitive zones on the VMS in animals, and thereby contains homologous chemosensitive 5-HT and Glut neurons. Very little is known about the chemoarchitecture of the Arc, particularly in relationship to the idea that it contains at least two, and possibly more, neurotransmitter systems involved in the mediation of chemosensitivity, as well as possible neurotransmitter–astrocyte interactions in this and/or other functions of the nucleus. As a step towards testing our hypotheses, we used immunohistochemistry with the PH8 antibody to detect tryptophan hydroxylase (TPOH), and specific antibodies for vesicular glutamate transporter 2 (VGLUT2), and glial fibrillary acidic protein (GFAP), to map the relative distribution of 5-HT neurons, Glut neurons, astrocytes respectively in the Arc. In addition, using specific antibodies, we mapped the distribution of 5-HT1A receptors, 5-HT2A receptors, and GluR5 kainate receptors in the Arc to examine the potential circuitry among different neuronal and astrocyte subtypes in the mediation of chemosensitivity. We selected these receptors in particular because agonists selective for each of the 5-HT1A, 5-HT2A, and GluR5 receptors alter respiratory function when applied to the VMS or raphé of animals (Lalley et al., 1994, Gillis et al., 1989, Rose et al., 1995, Teng et al., 2003, Nattie et al., 1988). In addition, we previously identified reductions in 5-HT receptor binding using the broad radioligand [3H] lysergic acid diethyl amide (LSD), and kainate receptor binding using [3H] kainate, in the Arc in SIDS cases with tissue section autoradiography (Panigrahy et al., 1997, Panigrahy et al., 2000). Due to the focus of our laboratory on putative disorders of central chemosensitivity in early life, we analyzed in this study the chemoarchitecture of the VMS in human infants.
Section snippets
Clinicopathologic database
The frozen medullae of four human infants were obtained from the Brain and Tissue Bank for Developmental Disorders at University of Maryland (Baltimore, MD). The postnatal ages of the cases were 3, 4, 6, and 6 months. The causes of death were cardiac tumor, hypothermia, and accidental asphyxia, in one instance from a plastic bag. In addition, medullas from two formalin-fixed, paraffin-embedded human cases at postnatal ages of 2 and 4 weeks were obtained from the autopsy service of the
Results
The relative distribution of each of the immunomarkers to neurons, processes, and astrocytes in the Arc is summarized in Table 2.
Discussion
The cellular mediation of chemosensitivity at the VMS is controversial and strongly debated, with proponents for one or another transmitter-specific phenotype. While various transmitter-specific neurons have been implicated in VMS chemosensitivity, e.g., acetylcholine (Dev and Loeschcke, 1979, Nattie, 1999, Nattie et al., 1989, Trouth et al., 1973), opioids (Neubauer et al., 1987, Trouth et al., 1993, Hurle et al., 1982, Wennergren and Wennergren, 1983), the leading candidates for central
Conclusions
Our observations have important implications for human disorders of chemosensitivity, including congenital central hypoventilation syndrome, sleep apnea, and SIDS. The delineation of the chemical anatomy directly in the human brain provides information fundamental to the establishment of the pathology in cases that come to autopsy. In SIDS, there are deficits in both 5-HT and kainate receptor binding density in the Arc (Panigrahy et al., 2000, Panigrahy et al., 1997). Given that 5-HT and Glut
Acknowledgement
This work was supported by grants from the Scottish Cot Death Trust, CJ Foundation for SIDS, First Candle/SIDS Alliance, CJ Murphy Foundation, National Institute of Child Health and Human Development (R37-HD20991and PO1-HD36379), and Children's Hospital Mental Retardation Core Grant (P30-HD18655).
References (87)
- et al.
Glial cells and neurotransmission: an inclusive view of synaptic function
Neuron
(2003) - et al.
A review of central 5-HT receptors and their function
Neuropharmacology
(1999) - et al.
Depletion of cholinergic neurons of the medullary arcuate nucleus in multiple system atrophy
Auton. Neurosci.
(2001) - et al.
Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease
Exp. Neurol.
(1997) - et al.
VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate
Trends Neurosci.
(2004) - et al.
Identification of serotonergic neurons in human brain by a monoclonal antibody binding to all three aromatic amino acid hydroxylases
Brain Res.
(1987) - et al.
Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease
Brain Res.
(1990) - et al.
Dopaminergic and noradrenergic sympathetic nerves of the dog have different DOPA decarboxylase activities
Neurosci. Lett.
(1986) - et al.
Astrocytic control of glutamatergic activity: astrocytes as stars of the show
Trends Neurosci.
(2004) - et al.
Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain
Neuroscience
(2004)